HIV-1 infection induces Vif-mediated SUMOylation of host RNA splicing factors important for proper viral RNA splicing

D Demetra P. Kelenis (Biochemistry and Molecular Biophysics, Columbia University) J Jeffrey R. Johnson (Microbiology, Icahn School of Medicine at Mount Sinai) S Simone Sidoli A Ann Emery (Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill) R Ronald Swanstrom (Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill) L Luke J. Hawkins (Biochemistry and Molecular Biophysics, Columbia University) K Kaila Mckie (Biochemistry and Molecular Biophysics, Columbia University) T Tegh Pawar (Biochemistry and Molecular Biophysics, Columbia University) S Stephen P. Goff (Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center)

Abstract

SUMOylation is a dynamically regulated post-translational modification involving covalent attachment of small ubiquitin-like modifiers (SUMOs) to lysine residues of target proteins. SUMOylation modulates multiple fundamental host cellular pathways, including pathways hijacked by HIV-1 to enable replication, but has not been explored by large-scale proteomics in the context of HIV-1 infection. Here, we performed a proteome-wide, mass spectrometry-based screen to identify proteins that are SUMOylated in response to HIV-1 infection. We show that infection with HIV-1 leads to the widespread increased SUMOylation of the heterogeneous nuclear ribonucleoprotein (HNRNP) A/B family. This phenotype was driven by expression of HIV-1 Viral Infectivity Factor (Vif), suggesting an unexplored function for this protein. Depletion of HNRNP A/B proteins led to altered splicing of HIV-1 viral RNAs and dramatically reduced HIV-1 infectivity. Our data suggest a mechanism involving HIV-1-induced, Vif-mediated SUMOylation of host RNA splicing factors as a means to regulate HIV-1 alternative splicing.

Article Details

Volume / Issue Vol. 123, Issue 18
Published May 05, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (9)

D

Demetra P. Kelenis

Biochemistry and Molecular Biophysics, Columbia University

J

Jeffrey R. Johnson

Microbiology, Icahn School of Medicine at Mount Sinai

S

Simone Sidoli

A

Ann Emery

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

R

Ronald Swanstrom

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

L

Luke J. Hawkins

Biochemistry and Molecular Biophysics, Columbia University

K

Kaila Mckie

Biochemistry and Molecular Biophysics, Columbia University

T

Tegh Pawar

Biochemistry and Molecular Biophysics, Columbia University

S

Stephen P. Goff

Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center